Moramide intermediate
Clinical data | |
---|---|
Other names | moramide intermediate |
Routes of administration | N/A |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
|
Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on
moramide precursor scheduled by UN Single Convention on Narcotic Drugs
.
In the United States, moramide intermediate is designated as a
Schedule II controlled substance,[2] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[3]
See also
- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B(norpethidine)
- Pethidine intermediate C(pethidinic acid)
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Controlled Substances - by DEA Drug Code Number
- ^ "DEA Diversion Control Division".